This inventor holds 5 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignee: Harvard College. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovator Spotlight: Hon Man Alex Ng
Introduction
Hon Man Alex Ng is a distinguished inventor based in Cambridge, MA, known for his significant contributions in the field of biotechnology and stem cell research. With a total of four patents to his name, Ng's work focuses on advanced methodologies for producing oligodendrocyte progenitor cells, which hold promising implications for neurological studies and treatments.
Latest Patents
Ng’s latest patents revolve around "Methods and compositions for the production of oligodendrocyte progenitor cells". These patents detail the creation of pluripotent stem cells through specific combinations of transcription factors aimed at producing oligodendrocyte progenitor cells (OPCs). His innovative approaches not only provide methods for producing these pluripotent stem cells but also outline their application in generating OPCs and oligodendrocytes, reinforcing the importance of his work in regenerative medicine.
Career Highlights
Currently affiliated with Harvard College, Hon Man Alex Ng has established himself as a prominent figure in his field, contributing valuable research on stem cell technologies. His innovative patents reflect his dedication to exploring and expanding the capabilities of stem cell applications in various medical contexts.
Collaborations
Throughout his career, Ng has collaborated with notable colleagues, including George M. Church and Parastoo Khoshakhlagh. These partnerships have further enriched his research endeavors, fostering an environment of creativity and innovation in tackling complex challenges within biotechnology.
Conclusion
Hon Man Alex Ng's contributions through his patents represent a significant advancement in the production of oligodendrocyte progenitor cells. His work at Harvard College, along with fruitful collaborations, positions him as a key innovator in the field, continuously pushing the boundaries of what is possible in stem cell research and its applications in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
